Cargando…
Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
Lysophosphatidic acid (LPA), a bioactive lipid molecule, has recently emerged as physiological and pathophysiological regulator in skeletal biology. Here we evaluate the effects of LPA on bone formation in vivo in murine femoral critical defect model. Primary femoral osteoblasts were isolated and tr...
Autores principales: | Yu, Zi-Li, Jiao, Bin-Fang, Li, Zu-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996417/ https://www.ncbi.nlm.nih.gov/pubmed/30003106 http://dx.doi.org/10.1155/2018/7537630 |
Ejemplares similares
-
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017) -
Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019) -
Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020) -
Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)